Scarica l'app Stockscreener
17.53
3.42%
0.58
Dopo l'orario di chiusura:
17.68
0.15
+0.86%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVCR Giù?
Forum
Previsione
Novocure Ltd Borsa (NVCR) Ultime notizie
NVCR|Novocure Ltd|Price:16.950|Chg%:-0.430 - TradingKey
Wall Street Analysts Think NovoCure (NVCR) Could Surge 53.68%: Read This Before Placing a Bet - Yahoo Finance
NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials ProgressHas The Bull Case Changed? - simplywall.st
First Trust Advisors LP Invests $1.03 Million in NovoCure Limited $NVCR - marketbeat.com
NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued - Sahm
NovoCure (NASDAQ:NVCR) Rating Increased to Buy at Wall Street Zen - MarketBeat
Novocure Ltd (NVCR) Stock Analysis & Forecast - TradingKey
NovoCure Ltd (038.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Quantinno Capital Management LP Has $27.11 Million Stock Position in NovoCure Limited $NVCR - MarketBeat
Novocure Stock Price Forecast. Should You Buy NVCR? - StockInvest.us
NovoCure (NVCR) Stock Looks Undervalued With Shares Down 90% Over Five Years - simplywall.st
Healthcare of Ontario Pension Plan Trust Fund Sells 201,000 Shares of NovoCure Limited $NVCR - MarketBeat
Novocure Hits Record Revenue & Raises 2026 Outlook - Streetwise Reports
Novocure Ltd (NVCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Novocure Posts Record Q2 Revenue of US$183.6M - Streetwise Reports
Novocure Ltd (NVCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NovoCure (NVCR) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
NovoCure Market Sentiment - Benzinga España
Wall Street Analysts Believe NovoCure (NVCR) Could Rally 46.63%: Here's is How to Trade - Yahoo Finance Singapore
Novocure Ltd (NVCR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NovoCure Ltd. (NVCRN) Q1 2023 Earnings ReportResults, Call & Slides - TipRanks
NovoCure (NVCR) Is Up 10.9% After Raising 2026 Revenue Outlook and Securing New CE Mark Approval – Has The Bull Case Changed? - simplywall.st
NovoCure Ltd. Revenue Breakdown – FWB:038 - TradingView
NovoCure Ltd. Revenue Breakdown – LSX:A140ML - TradingView
NovoCure Ltd. (NVCRN) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
NovoCure (NVCR) Lifts 2026 Guidance After Record Quarter While Fair Value Debate Builds - Yahoo Finance UK
TradingKey - TradingKey
Novocure Ltd (NVCR) Cash Flow - TradingKey
NovoCure (NVCR) Stock Faces Ongoing Losses As Q2 2026 EPS Narrows To $0.13 Loss - simplywall.st
Novocure Ltd (NVCR) Institutional Confidence - TradingKey
NVCR Maintained by Wedbush -- Price Target Raised to $20.00 - GuruFocus
H.C. Wainwright cuts NovoCure stock price target to $32 on valuation - Investing.com UK
Novocure Is Maintained at Neutral by Wedbush - Moomoo
NovoCure Posts Record Revenue and Raises Guidance, But NVCR Stock Tumbles Over 6% - finance.biggo.com
NovoCure's Strongest Quarter Ever Isn't Enough to Stop NVCR Stock From Sliding - Benzinga
Form 144 NovoCure Limited For: 24 July By Investing.com - Investing.com Nigeria
NovoCure (NVCR) Stock Soars 28% on Milestone Quarter and Strong Revenue Forecast - Blockonomi
NovoCure (NVCR) Stock Jumps 28% After Record Revenue and Raised Guidance - CoinCentral
NovoCure Q2 2026 slides: profitability in sight, guidance raised By Investing.com - Investing.com Nigeria
Novocure Ltd earnings beat by $0.20, revenue topped estimates - Investing.com Nigeria
Novocure Cash, Cash Equivalents and Short-Term Investments Were $440.6M as of June 30 >NVCR - Moomoo
BR:N2VC34 Stock Latest News - TipRanks
NovoCure (NVCR) Breaks Out on Q2 2026 EarningsOptune Pax Driving Recovery - TradingKey
Novocure (NVCR) Hits New High on Optimistic Outlook, FDA Approval Hopes - Yahoo Finance
NovoCure Earnings Call Highlights Growth With Caution - TipRanks
NVCR Maintained by HC Wainwright & Co. -- Price Target Raised to $52 - GuruFocus
Earnings call transcript: NovoCure beats Q2 2026 forecasts, shares jump 16% - Investing.com Nigeria
NovoCure Ltd SEC Filing (Jul 23, 2026) - Stock Titan
NVCR Stock Surges 28% For Best Day In Over 1.5 Years — What’s Driving The Rally? - Yahoo Finance
NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Rev - GuruFocus
NovoCure Ltd (NVCR) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
NovoCure's Q2 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Raised - Moomoo
NovoCure Shares Surge 29% on Q2 Results, 2026 Forecast Raised - TechStock²
Crude Oil Rises Sharply; T-Mobile Shares Fall Following Q2 Results - Benzinga
Is Novocure Ltd (NVCR) Positioned for Growth After Q2 Earnings? - GuruFocus
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Top U.S. trending stocks: NovoCure leads with 23.4% surge - Investing.com
2.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):